Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ACCORD HLTHCARE

  • FDA Approval
  • Dec. 09, 2022, 12:41 UTC
  • 27
  • 0 comments

FDA approve BENDAMUSTINE HYDROCHLORIDE

Comment Full text

B BRAUN

  • FDA Approval
  • Dec. 09, 2022, 12:41 UTC
  • 25
  • 0 comments

FDA approve POTASSIUM CHLORIDE

Comment Full text

BAXTER HLTHCARE

  • FDA Approval
  • Dec. 09, 2022, 09:30 UTC
  • 25
  • 0 comments

FDA approve DEXTROSE

Comment Full text

SLAYBACK PHARMA LLC

  • FDA Approval
  • Dec. 09, 2022, 09:30 UTC
  • 27
  • 0 comments

FDA approve BENDAMUSTINE HYDROCHLORIDE

Comment Full text

AZURITY

  • FDA Approval
  • Dec. 09, 2022, 09:30 UTC
  • 24
  • 0 comments

FDA approve TRIPTORELIN PAMOATE

Comment Full text

UPJOHN

  • FDA Approval
  • Dec. 09, 2022, 09:30 UTC
  • 24
  • 0 comments

FDA approve ATORVASTATIN CALCIUM

Comment Full text

BAXTER HLTHCARE

  • FDA Approval
  • Dec. 09, 2022, 09:30 UTC
  • 25
  • 0 comments

FDA approve SODIUM CHLORIDE

Comment Full text

SOMERSET

  • FDA Approval
  • Dec. 09, 2022, 09:30 UTC
  • 23
  • 0 comments

FDA approve LATANOPROST

Comment Full text

BAMF

  • FDA Approval
  • Dec. 09, 2022, 09:30 UTC
  • 30
  • 0 comments

FDA approve SODIUM FLUORIDE F-18

Comment Full text

INVAGEN PHARMS

  • FDA Approval
  • Dec. 09, 2022, 09:30 UTC
  • 27
  • 0 comments

FDA approve VILAZODONE HYDROCHLORIDE

Comment Full text
  • Previous
  • 926
  • 927
  • 928
  • 929
  • 930
  • Next

Search

News categories

  • Technical Exchange News(12315)
  • Event(6229)
  • SEC News(267589)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(155761)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin